Xi Cao Overview
- Firm
- Monolith Managem...
- Primary Position
-
Co-Founder & Man...
- Primary Industry
-
Information Technology
- Med. Deal Size
-
- Med. Valuation
-
Xi Cao General Information
Biography
Mr. Xi Cao is a Co-Founder of Monolith Management. He is the former venture partner of Sequoia Capital China. Prior to founding Monolith Management, He had worked at Tencent and joined Sequoia Capital in 2013. He became a partner at Sequoia Capital China Fund and played a pivotal role in establishing the Sequoia China Seed Fund in 2018. He has extensive experience in early and growth stage investments, with notable ventures in Kuaishou, Douyu, Super Monkey, Tencent Music, Enhe Biotech, METIS Pharmaceuticals, MetaX Tech, Taichi Graphics, and Houmo Intelligent Technology.
Contact Information
Address
- 43/F, Room 33, Champion Tower
- Three Garden Road, Central
- Hong Kong
- Hong Kong
Xi Cao Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Monolith Management | Investor | Co-Founder & Managing Partner | Hong Kong, Hong Kong | Hedge Fund |
Xi Cao Lead Partner on Deals (7)
Xi Cao has been the lead partner on 7 deals. Their latest deal was with Beatbot, a computers, parts and peripherals company. The deal was made for on 15-Aug-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Beatbot | 15-Aug-2024 | Early Stage VC (Series A) | Completed | Computers, Parts and Peripherals | Suzhou, China | |
| Metis Pharmaceuticals | 06-Apr-2022 | Completed | Discovery Tools (Healthcare) | Hangzhou, China | ||
| Surreal AI | 30-Aug-2021 | Completed | Automation/Workflow Software | Shenzhen, China | ||
| Surreal AI | 02-Mar-2021 | Completed | Automation/Workflow Software | Shenzhen, China | ||
| neoX Biotech | 01-Feb-2021 | Completed | Drug Discovery | Beijing, China | ||
| HOUMO.AI | 01-Sep-2020 | Seed Round | Completed | Application Specific Semiconductors | Nanjing, China | |
| Sudo Privacy | 04-Sep-2019 | Seed Round | Completed | Network Management Software | Beijing, China |
Xi Cao Network (11)
Portfolio Executives (11)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Shengle Wang | Beatbot | Founder, Chairman & Chief Executive Officer | 15-Aug-2024 | Suzhou, China |
| Mark Herbert | Metis Pharmaceuticals | Chief Business Officer | 06-Apr-2022 | Hangzhou, China |
| Metis Pharmaceuticals | Co-Founder & Chief Executive Officer | 06-Apr-2022 | Hangzhou, China | |
| Metis Pharmaceuticals | Co-Founder, President & Head | 06-Apr-2022 | Hangzhou, China | |
| Metis Pharmaceuticals | Chief Operating Officer & Co-Founder | 06-Apr-2022 | Hangzhou, China |
Xi Cao FAQs
-
Who is Xi Cao?
Mr. Xi Cao is a Co-Founder of Monolith Management.
-
How much does Xi Cao typically invest?
Xi Cao's median deal size is .
-
What is Xi Cao’s main position?
Xi Cao’s primary position is Co-Founder & Managing Partner.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
